Indivior (LON:INDV) Share Price Passes Below Fifty Day Moving Average of $888.47

Indivior PLC (LON:INDVGet Free Report) passed below its 50 day moving average during trading on Monday . The stock has a 50 day moving average of GBX 888.47 ($11.86) and traded as low as GBX 676.23 ($9.03). Indivior shares last traded at GBX 680 ($9.08), with a volume of 363,132 shares.

Analyst Upgrades and Downgrades

Separately, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a GBX 1,500 ($20.02) price objective on shares of Indivior in a report on Thursday, September 5th.

Check Out Our Latest Analysis on Indivior

Indivior Price Performance

The company has a quick ratio of 1.52, a current ratio of 0.85 and a debt-to-equity ratio of 2,790.00. The company has a market capitalization of £895.85 million, a price-to-earnings ratio of -871.79, a PEG ratio of -5.57 and a beta of 0.19. The stock’s 50-day simple moving average is GBX 888.47 and its two-hundred day simple moving average is GBX 1,237.98.

Insider Buying and Selling

In other news, insider Jo Le Couilliard acquired 1,490 shares of Indivior stock in a transaction that occurred on Friday, July 26th. The stock was purchased at an average cost of GBX 1,006 ($13.43) per share, with a total value of £14,989.40 ($20,007.21). 3.39% of the stock is currently owned by insiders.

About Indivior

(Get Free Report)

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.

Further Reading

Receive News & Ratings for Indivior Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Indivior and related companies with MarketBeat.com's FREE daily email newsletter.